Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1046522> ?p ?o }
Showing triples 1 to 35 of
35
with 100 triples per page.
- Q1046522 subject Q8460853.
- Q1046522 abstract "Abacavir/lamivudine/zidovudine (INNs, trade name Trizivir) is a pharmaceutical treatment for HIV infection. It is a fixed dose combination of three reverse transcriptase inhibitors patented by GlaxoSmithKline and now marketed by its joint venture with Pfizer, ViiV Healthcare:abacavir (ABC)lamivudine (3TC)zidovudine (AZT or ZDV)It is indicated in the treatment of AIDS/HIV. For this purpose, the combination is very useful in pregnant women to decrease the risk of mother-to-child transmission.The combination of drugs helps to reduce HIV's resistance (through mutation) to the drugs individually. Of the three, AZT and ABC have passed out of United States patent protection.In December 2013, Lupin Limited launched a generic version of Trizivir.".
- Q1046522 atcPrefix "J05".
- Q1046522 atcSuffix "AR04".
- Q1046522 casNumber "364057-50-1".
- Q1046522 thumbnail Abacavir,_lamivudine_and_zidovudine.svg?width=300.
- Q1046522 wikiPageWikiLink Q11995.
- Q1046522 wikiPageWikiLink Q12199.
- Q1046522 wikiPageWikiLink Q12988589.
- Q1046522 wikiPageWikiLink Q18208897.
- Q1046522 wikiPageWikiLink Q198504.
- Q1046522 wikiPageWikiLink Q206921.
- Q1046522 wikiPageWikiLink Q212322.
- Q1046522 wikiPageWikiLink Q253623.
- Q1046522 wikiPageWikiLink Q28774.
- Q1046522 wikiPageWikiLink Q304330.
- Q1046522 wikiPageWikiLink Q4113827.
- Q1046522 wikiPageWikiLink Q421559.
- Q1046522 wikiPageWikiLink Q422631.
- Q1046522 wikiPageWikiLink Q4663143.
- Q1046522 wikiPageWikiLink Q5456317.
- Q1046522 wikiPageWikiLink Q7929051.
- Q1046522 wikiPageWikiLink Q824258.
- Q1046522 wikiPageWikiLink Q8460853.
- Q1046522 atcPrefix "J05".
- Q1046522 atcSuffix "AR04".
- Q1046522 casNumber "364057".
- Q1046522 type ChemicalSubstance.
- Q1046522 type Drug.
- Q1046522 type ChemicalObject.
- Q1046522 type Thing.
- Q1046522 type Q8386.
- Q1046522 comment "Abacavir/lamivudine/zidovudine (INNs, trade name Trizivir) is a pharmaceutical treatment for HIV infection. It is a fixed dose combination of three reverse transcriptase inhibitors patented by GlaxoSmithKline and now marketed by its joint venture with Pfizer, ViiV Healthcare:abacavir (ABC)lamivudine (3TC)zidovudine (AZT or ZDV)It is indicated in the treatment of AIDS/HIV.".
- Q1046522 label "Abacavir/lamivudine/zidovudine".
- Q1046522 depiction Abacavir,_lamivudine_and_zidovudine.svg.